MyFinsight
Home
Blog
About
Inventory, net
$2,290,254
(20.69%↑ Y/Y)
Cash and cash
equivalents
$2,047,596
(-74.53%↓ Y/Y)
Accounts receivable
$1,098,965
Prepaid expenses
$318,940
(36.67%↑ Y/Y)
Deferred offering costs
$33,046
Total current assets
$5,788,801
(-43.08%↓ Y/Y)
Property and equipment,
net
$202,333
(-35.68%↓ Y/Y)
Right-of-use asset
$166,751
(-41.21%↓ Y/Y)
Intangible assets, net
$28,210
(-44.17%↓ Y/Y)
Total assets
$6,186,095
(-42.82%↓ Y/Y)
Total liabilities and
stockholders equity
$6,186,095
(-42.82%↓ Y/Y)
Total stockholders
equity
$3,767,543
(-53.93%↓ Y/Y)
Total liabilities
$2,418,552
(-8.46%↓ Y/Y)
Accumulated deficit
-$84,436,030
(-9.67%↓ Y/Y)
Additional paidin capital
$88,194,870
(3.61%↑ Y/Y)
Total current
liabilities
$2,041,427
(43.18%↑ Y/Y)
Warrant liability
$303,805
(-70.81%↓ Y/Y)
Operating lease
liability, long term
$73,320
(-58.19%↓ Y/Y)
Common stock, 0.001 par
value 100,000,000...
$8,703
(-82.53%↓ Y/Y)
Accrued expenses and
other liabilities
$1,135,711
(18.54%↑ Y/Y)
Accounts payable
$905,716
(93.64%↑ Y/Y)
Back
Back
Balance Sheet
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
source: myfinsight.com